Tag Archives: treatment of thromboembolic diseases

Boehringer Ingelheim: New Pradaxa® data for treatment of thromboembolic diseases to be presented at ESC Congress 2014, 30th August – 3rd September, 2014 in Barcelona

• HOTLINE: New results from RE-LY® compare the effect of warfarin and Pradaxa® on kidney function in patients requiring anticoagulation • HOTLINE: GLORIA™-AF Registry Program benchmarks patient characteristics and antithrombotic use for stroke prevention in AF worldwide For Non-US/Non-UK/Non-Canadian Media … Read the full press release